Soft Tissue Allografts Market Share
Soft Tissue Allografts Market | Allergan completed the acquisition of Acelity L.P. Inc.’s LifeCell Corporation for US$2.9 bn in February 2017.
Soft Tissue Allografts Market | Allergan completed the acquisition of Acelity L.P. Inc.’s LifeCell Corporation for US$2.9 bn in February 2017.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Soft</strong> <strong>Tissue</strong> <strong>Allografts</strong> <strong>Market</strong> - Global Industry Analysis, Size,<br />
<strong>Share</strong>, Growth, Trends and Forecast 2017 - 2025<br />
A fresh study by Transparency <strong>Market</strong> Research (TMR) notifies that the<br />
global soft tissue allografts market was dominated by Allergan, plc. in 2016,<br />
and the company is poised to sustain its strong market position in the near<br />
future via its impressive product portfolio, geographical presence, and<br />
frequent strategic acquisitions. For example, Allergan completed the<br />
acquisition of Acelity L.P. Inc.’s LifeCell Corporation for US$2.9 bn in<br />
February 2017. This move will help the company to make a foray into<br />
regenerative medicine and add to its high-quality and durable portfolio.<br />
Besides the commercial products of LifeCell, Allergan will also acquire the<br />
New Jersey Company’s innovative manufacturing capabilities and its<br />
research and development operations.<br />
Browse Full Research Report:<br />
https://www.transparencymarketresearch.com/soft-tissue-allograftsmarket.html<br />
The TMR report also identifies some of the other prominent companies<br />
currently operating in the global soft tissue allografts market, namely Zimmer<br />
Biomet, Lattice Biologics Ltd., AlonSource Group, AlloSource, MiMedix<br />
Group, Inc., CONMED Corporation, Organogenesis Inc., RTI Surgical, Inc.,<br />
Integra LifeSciences Corporation, Globus Medical Inc, Straumann Holding<br />
AG, Osiris Therapeutics, Inc., Arthrex, Inc., Xtant Medical, Alliqua<br />
BioMedical, Inc, C. R. Bard, Inc (Davol Inc.), B. Braun Melsungen AG, and<br />
Bone Bank Allograft.<br />
As per the projections of the TMR report, the demand in the global soft tissue<br />
allografts market will swell at a healthy CAGR of 6.3% during the forecast<br />
period of 2017 to 2025. The report estimates the market for soft tissue<br />
allografts, across the world, to be worth US$6.2 bn by the end of 2025,<br />
substantially up from its evaluated valuation of US$3.6 bn in 2016. Based on
product type, collagen allograft was the most profitable segment, owing to its<br />
applications in aesthetics surgery, wound care, and orthopedic surgeries.<br />
Application-wise, wound care category held major market share in 2016,<br />
followed by dentistry. Geographically, North America currently serves the<br />
maximum demand in the global soft tissue allografts market.<br />
For well over a century, soft tissue allografts have been considered a<br />
successful procedure, and each year, nearly 1 million allografts are<br />
transplanted in the U.S. alone. <strong>Soft</strong> tissue allografts are substitute tissues that<br />
are used to reconstruct deficient ligaments, spinal surgery, torn menisci, and<br />
osteochondral defects during knee surgery. <strong>Soft</strong> tissue allografts undergo a<br />
three-stage safety screening process of donor screening, laboratory testing,<br />
and tissue preparation. <strong>Soft</strong> tissue allografts can be made up of bone, tendons,<br />
cartilage, skin, heart valves, and veins used for transplant in different types of<br />
surgeries.<br />
In the recent past, the usage of soft tissue allografts has grown due to increase<br />
in the number of cases in dental implants and orthopedic surgery. Escalating<br />
geriatric population, growing demand for new technological advancement for<br />
production of new tissues by tissue banks, and rise in demand of soft tissue<br />
allografts among athletes of numerous sports and other walks of life are some<br />
of the key factors driving the demand in the global soft tissue allografts<br />
market. Increase in ACL surgery, escalating incidences of diabetes foot ulcer,<br />
growing popularity of cosmetic surgery to treat facial disorders with new<br />
technologies are some of the other factors favoring the global soft tissue<br />
allografts market.<br />
While high cost of procedures continues to challenge the market for soft<br />
tissue allografts, especially in the emerging economies, the lack of defined
eimbursement policies is also obstructing the market expansion. In addition<br />
to that, complications pertaining to increased risk of infection and immune<br />
response such as disruption of infected anastomotic rigid line with a rupture,<br />
microbial infection, and bowel formation is hindering the proper prosperity of<br />
the global soft tissue allografts market.<br />
Browse Full Press Release:<br />
Press Release
About Us<br />
Transparency <strong>Market</strong> Research (TMR) is a global market intelligence<br />
company providing business information reports and services. The<br />
company’s exclusive blend of quantitative forecasting and trend analysis<br />
provides forward-looking insight for thousands of decision makers. TMR’s<br />
experienced team of analysts, researchers, and consultants use proprietary<br />
data sources and various tools and techniques to gather and analyze<br />
information.<br />
TMR’s data repository is continuously updated and revised by a team of<br />
research experts so that it always reflects the latest trends and information.<br />
With extensive research and analysis capabilities, Transparency <strong>Market</strong><br />
Research employs rigorous primary and secondary research techniques to<br />
develop distinctive data sets and research material for business reports.<br />
Contact Us<br />
Transparency <strong>Market</strong> Research<br />
State Tower,<br />
90 State Street, Suite 700,<br />
Albany NY - 12207<br />
United States<br />
USA - Canada Toll Free: 866-552-3453<br />
Email: sales@transparencymarketresearch.com<br />
Website: http://www.transparencymarketresearch.com